Geriatric Assessment Reporting in Real Time (GARRT) in Non-electively Hospitalized Older Cancer Patients
NCT ID: NCT03951090
Last Updated: 2019-05-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
148 participants
INTERVENTIONAL
2016-04-25
2018-04-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
LCCC1931:Post-treatment Intervention in Women With Breast Cancer (70y/o+)
NCT04292847
Improving the Approach to and Management of the Older Metastatic Breast Cancer Patient
NCT03007641
Incorporating Biometric Data for Patients Receiving Concurrent Chemotherapy & RT
NCT05937659
Screening of Bone Mineral Density in Women Who Have Received Chemotherapy
NCT00603551
Breast Cancer Screening for Underserved Women: Comparing Outcomes and Lowering Recall Rates With 3D- vs. 2D-mammography
NCT03979729
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study will compare the referral rates of participants in each group to determine if providing real-time results of the geriatric assessment impact referral rates.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
GARRT Arm
Participants in this arm complete an brief geriatric assessment, and the results of these assessments are given to providers with recommendations to address deficits identified by the geriatric assessment
Results of the brief geriatric assessment
Providers will receive results of the brief geriatric assessment with recommendations for address deficits identified through the results of the brief geriatric assessment
Control Arm
Providers of participants of this group will not receive the results of the brief geriatric assessments. These participants will receive standard of care treatment
No results of brief geriatric assessments
Providers will not receive results of the brief geriatric assessment. Participants will receive standard of care treatment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Results of the brief geriatric assessment
Providers will receive results of the brief geriatric assessment with recommendations for address deficits identified through the results of the brief geriatric assessment
No results of brief geriatric assessments
Providers will not receive results of the brief geriatric assessment. Participants will receive standard of care treatment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* English speaking.
* Admitted to UNC Hospitals non-electively within 72 hours.
* Biopsy proven solid tumor or myeloma or lymphoma.
* Newly diagnosed cancer patients for whom active cancer directed therapy is planned within the next six months or patients on active cancer directed therapy either currently or within the previous 6 months.
* Signed written IRB-approved informed consent.
Exclusion Criteria
* Patients who are admitted to an intensive care setting.
* Patients with acute myeloma lymphoma (AML) or other high grade hematologic malignancies.
* Patients undergoing bone marrow transplant or admitted to the bone marrow transplant unit.
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
UNC Lineberger Comprehensive Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Trevor Jolly, MBBS
Role: PRINCIPAL_INVESTIGATOR
UNC Lineberger Comprehensive Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UNC Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LCCC 1538
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.